What is Coridea?
Coridea is a specialized entity focused on the development of high-impact solutions designed to enhance patient outcomes. The company operates with a dual objective: to deliver significant returns for its investors while advancing healthcare innovation. Coridea has a proven track record, having successfully founded 15 companies and generated over $1.6 billion in returns for its investors. Furthermore, the company has demonstrated its commitment to cutting-edge research by securing more than $12 million in NIH grants, highlighting its dedication to pioneering new medical solutions. Its target clientele includes patients seeking advanced medical treatments and investors looking for profitable opportunities within the healthcare sector.
How much funding has Coridea raised?
Coridea has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Coridea?
With its large-scale late-stage funding, Coridea is poised for accelerated expansion and further development of its innovative healthcare solutions. The recent strategic investment is likely to fuel the company's efforts in scaling its operations, potentially through the acquisition of new technologies, the expansion of its research and development pipeline, or the strategic growth of its portfolio companies. This infusion of capital will enable Coridea to solidify its market position and continue its mission of improving patient care while delivering value to its investors. The company's history of successful ventures and substantial investor returns suggests a robust strategy for future growth and profitability.
See full Coridea company page
